Vinay Prasad

Person

Former director of FDA's Center for Biologics Evaluation and Research (CBER)

3 stories

White House Intervention Gave Replimune Cancer Drug a Third Chance After Two FDA Rejections

politics34d ago

Second FDA Senior Official Departs in Less Than a Week as Top Drug Regulator Claims She Was Fired

FDA Withdraws Publication of COVID and Shingles Vaccine Research Findings